Concepedia

Daniel G. Marquess

DG

28

Publications

1.3K

Citations

19

H-Index

1990

Active since

Affiliations

Theravance Biopharma (United States)(Current)

University of Hertfordshire

Advanced Pharma

Stanford University

Oxford Centre for Mission Studies

Daniel G. Marquess is an author at Theravance Biopharma (United States) specializing in biochemistry, natural sciences, and medicine.

Top concepts

Publications per year

1990–2018

28

Publications

28

The Pinene Path to Taxanes. 6. A Concise Stereocontrolled Synthesis of Taxol

Paul A. Wender, Neil F. Badham, Simon P. Conway et al. · Journal of the American Chemical Society · 1997 · 247 citations

, , +15

The Pinene Path to Taxanes. 5. Stereocontrolled Synthesis of a Versatile Taxane Precursor

Paul A. Wender, Neil F. Badham, Simon P. Conway et al. · Journal of the American Chemical Society · 1997 · 172 citations

, , +12

The 5‐HT<sub>4</sub> receptor agonist, tegaserod, is a potent 5‐HT<sub>2B</sub> receptor antagonist <i>in vitro</i> and <i>in vivo</i>

David T. Beattie, Jacqueline A.M. Smith, Daniel G. Marquess et al. · British Journal of Pharmacology · 2004 · 119 citations · Full text

An octameric carbopeptoid; secondary structure in octameric and tetrameric 5-aminomethyl-tetrahydrofuran-2-carboxylates

Timothy D. W. Claridge, Daniel D. Long, Natasha L. Hungerford et al. · Tetrahedron Letters · 1999 · 69 citations

, , +4

From sequencamers to foldamers? Tetrameric furanose carbopeptoids from cis- and trans-5-aminomethyl-tetrahydrofuran-2-carboxylates

Daniel D. Long, Natasha L. Hungerford, Martin D. Smith et al. · Tetrahedron Letters · 1999 · 58 citations

, , +9

Rows per page

1–5 of 28